Clinical evidence and treatment requirements related to heart failure in type 2 diabetes mellitus

被引：2
|
作者：
Cai, Xiao-Ling [1 ]
Wang, Xiang-Qing [1 ]
Ji, Li-Nong [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100044, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2020年 / 133卷 / 10期
基金：
中国国家自然科学基金;
关键词：
CARDIOVASCULAR OUTCOMES; MORTALITY; RISK;
D O I：
10.1097/CM9.0000000000000732
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1135 / 1137
页数：3
相关论文
共 50 条
  • [21] Thiazolidinediones in type 2 diabetes mellitus - Current clinical evidence
    Diamant, M
    Heine, RJ
    DRUGS, 2003, 63 (13) : 1373 - 1405
  • [22] Type 2 diabetes mellitus in patients with terminal stage heart failure
    Doka, G.
    Mlynarova, J.
    Krenek, P.
    Musil, P.
    Klimas, J.
    Goncalvesova, E.
    Kyselovic, J.
    DIABETOLOGIA, 2014, 57 : S504 - S504
  • [23] Consensus document: management of heart failure in type 2 diabetes mellitus
    Upendra Kaul
    Saumitra Ray
    D. Prabhakar
    Arun Kochar
    Kamal Sharma
    Prakash Kumar Hazra
    Subhash Chandra
    Dharmesh Ramakant Bhai Solanki
    Anjan Lal Dutta
    Viveka Kumar
    M. Srinivas Rao
    Abraham Oomman
    Sameer Dani
    Brian Pinto
    T. R. Raghu
    Heart Failure Reviews, 2021, 26 : 1037 - 1062
  • [24] Consensus document: management of heart failure in type 2 diabetes mellitus
    Kaul, Upendra
    Ray, Saumitra
    Prabhakar, D.
    Kochar, Arun
    Sharma, Kamal
    Hazra, Prakash Kumar
    Chandra, Subhash
    Solanki, Dharmesh Ramakant Bhai
    Dutta, Anjan Lal
    Kumar, Viveka
    Rao, M. Srinivas
    Oomman, Abraham
    Dani, Sameer
    Pinto, Brian
    Raghu, T. R.
    HEART FAILURE REVIEWS, 2021, 26 (05) : 1037 - 1062
  • [25] TELMISARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES MELLITUS TYPE 2
    Pavliukovych, N.
    Pavliukovych, O.
    Kozar, M.
    ATHEROSCLEROSIS, 2022, 355 : E330 - E330
  • [26] Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
    Kato, Eri T.
    Silverman, Michael G.
    Mosenzon, Ofri
    Zelniker, Thomas A.
    Cahn, Avivit
    Furtado, Remo H. M.
    Kuder, Julia
    Murphy, Sabina A.
    Bhatt, Deepak L.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Wilding, John P. H.
    Bonaca, Marc P.
    Ruff, Christian T.
    Desai, Akshay S.
    Goto, Shinya
    Johansson, Peter A.
    Gause-Nilsson, Ingrid
    Johanson, Per
    Langkilde, Anna Maria
    Raz, Itamar
    Sabatine, Marc S.
    Wiviott, Stephen D.
    CIRCULATION, 2019, 139 (22) : 2528 - 2536
  • [27] The incidence of chronic heart failure in patients with type 2 diabetes mellitus
    Yeshniyazov, N. B.
    Medovchshikov, V. V.
    Tereshchenko, E. A.
    Khasanova, E. R.
    Kobalava, Z. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 253 - 253
  • [28] Clinical characteristics associated with the presence of echocardiographic phenotypes of heart failure in patients with type 2 diabetes mellitus
    Yeshniyazov, N. Nurlan
    Medovchshikov, V. V.
    Bayarsaikhan, M.
    Khasanova, E. R.
    Gudieva, K. M.
    Kobalava, Z. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 324 - 324
  • [29] Newly and previously diagnosed type 2 diabetes mellitus: differences in the incidence of heart failure and clinical characteristics
    Medovchshikov, V. Vadim
    Yeshniyazov, N. B.
    Bayarsaikhan, M.
    Khasanova, E. R.
    Gudieva, K. M.
    Kobalava, Z. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 325 - 325
  • [30] TREATMENT OPTIMISATION OF HEART FAILURE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CONCOMITANT TYPE 2 DIABETES MELLITUS
    Spivak, Yu. A.
    Potyazhenko, M. M.
    Lyulka, N. O.
    Vakulenko, K. Ye.
    Nos, Ya. V.
    WORLD OF MEDICINE AND BIOLOGY, 2022, 81 (03): : 183 - 187
12345